Ondansetron Stada (Ondansetron Hydrochloride Dihydrate)

Ondansetron, the active ingredient in Ondansetron Stada, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use. It treats nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult and pediatric patients. GNH USA supplies Ondansetron Stada as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Ondansetron Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Ondansetron Stada ​        ...  …  … … … ...  … … … … … … … … … … … …  … …